SCHEMBL7545306

SCHEMBL7545306

CC(C)(C)OC(=O)NNc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.53
ESR2 Q92731 1/20 0.49
GPR119 Q8TDV5 1/20 0.46
TTK P33981 1/20 0.46
PTPN5 P54829 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
FFAR1 O14842 1/20 0.41
AKR1B1 P15121 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
EGLN2 Q96KS0 2/20 0.40
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
CTSS P25774 2/20 0.38
CTSK P43235 1/20 0.38
NAMPT P43490 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164774 0.88 TTK (0.55) PTPN1ESR2GPR119TTKPTPN5
SCHEMBL6959964 0.79 PTPN1 (0.57) PTPN1ESR2GPR119PTPN5FFAR1
SCHEMBL15540186 0.78 EGLN2 (0.45) MEN1NPC1GAARAB9AKMT2A
SCHEMBL6957195 0.77 PTPN1 (0.56) PTPN1ESR2GPR119FFAR1AKR1B1
SCHEMBL4254852 0.76 GAA (0.60) MEN1NPC1GAARAB9AKMT2A
SCHEMBL6956218 0.75 PTPN1 (0.54) PTPN1GPR119FFAR1AKR1B1S1PR1
Methylamine SCHEMBL8701837 0.75 GPR119 (0.53) PTPN1ESR2GPR119PTPN5FFAR1
SCHEMBL8196446 0.75 CYP17A1 (0.51) MEN1NPC1GAARAB9AKMT2A
SCHEMBL6957139 0.75 PTPN1 (0.53) PTPN1GPR119FFAR1AKR1B1S1PR1
SCHEMBL6956199 0.74 PTPN1 (0.52) PTPN1GPR119GAAFFAR1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876336-B1 AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES NOVARTIS AG (CH) 2002-06-05 EP disclosed
US-6225345-B1 FOR THERAPY OF ACQUIRED IMMUNODEFICIENCY SYNDROME NOVARTIS AG (CH) 2001-05-01 US disclosed